Searchable abstracts of presentations at key conferences in endocrinology

ea0090oc7.3 | Oral Communications 7: Pituitary and Neuroendocrinology 2 | ECE2023

The mesenchymal stem cells induce immunosuppressive microenvironment in pituitary tumors

Marrero-Rodriguez Daniel , Taniguchi Keiko , A Cortes-Morales Victor , Valenzuela-Perez Alejandra , Vela-Patino Sandra , Cano-Zaragoza Amayrani , Martinez Florencia , Kerbel Jacobo , Andonegui-Elguera Sergio , Gomez-Apo Erick , Chavez-Macias Laura , Montesinos Juan Jose , Mercado Moises

The tumor microenvironment (TME) includes diverse cellular components such as mesenchymal stem cells (MSC) and immune cells. MSC are a subset of heterogeneous cell populations characterized by the expression of CD105, CD73, and CD90 that can differentiate into chondrocytes, osteoblasts, and adipocytes in vitro. They are known to have immunomodulatory capabilities. Our aim was to isolate and characterize the immunomodulatory capabilities of MSC from pituitary tumors (P...

ea0090rc6.2 | Rapid Communications 6: Endocrine-related Cancer | ECE2023

Refocusing on somatostatin receptors as clinical targets in pheochromocytomas and paragangliomas

Garcia Vioque Victor , Trinidad Moreno Montilla Maria , Blazquez Encinas Rey Ricardo , Mangili Federica , Martinez Montes Angel Mario , Alors-Perez Emilia , Culler Michael D , Pedraza-Arevalo Sergio , Robledo Mercedes , P. Castano Justo , Ibanez Costa Alejandro

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine neoplasms (NENs) that arise in the adrenal medulla and paraganglia, respectively. As occurs in the rest of NENs, PPGLs commonly present a high density of somatostatin receptors (SSTs) on their membrane. However, unlike in most NENs, somatostatin analogues (SSAs) do not represent a suitable therapeutic target in PPGLs, and the mechanisms underlying this mismatch are still unclear. In this study, we aim to iden...

ea0090rc9.1 | Rapid Communications 9: Adrenal and Cardiovascular Endocrinology 2 | ECE2023

Symptoms of glucocorticoid-induced adrenal insufficiency – A systematic evaluation of clinician- and patient-reported symptoms and their rated relevance

Lund Marie Louise , Bjorner Jakob Bue , Al-Jorani Hajir , Boesen Victor Brun , Dreyer Anja Fenger , Boggild Hansen Simon , Jorgensen Nanna Thurmann , Klose Marianne , Tei Randi , Watt Torquil , Feldt-Rasmussen Ulla , Borresen Stina Willemoes

Context: Glucocorticoid-induced adrenal insufficiency is the most frequent type of adrenal insufficiency, but its symptomatology has not been thoroughly studied.Objective: To describe the predominant symptoms experienced by patients with glucocorticoid-induced adrenal insufficiency and rate these symptoms’ significance for patients’ perceived need for supplemental hydrocortisone stress dose.Methods: The 80 symptoms in the...

ea0090p109 | Endocrine-related Cancer | ECE2023

Clinical implications of splicing machinery alteration in Pheochromocytomas and Paragangliomas

Trinidad Moreno Montilla Maria , Garcia Vioque Victor , Blazquez Encinas Rey Ricardo , Mario Martinez Montes Angel , Alors-Perez Emilia , Mangili Federica , Pedraza-Arevalo Sergio , Robledo Mercedes , Castano Justo P. , Ibanez Costa Alejandro

Pheochromocytomas and paragangliomas (PPGL) are infrequent neuroendocrine neoplasms, which develop metastases or aggressive behaviour in 25 % patients. They can be classified into three clusters according to their molecular features; nevertheless, these differences may not stratify patients according to their prognosis. The dysregulation of the splicing process has emerged as a novel feature shared by most cancers, which is associated with an aggressive phenotype in several tu...

ea0090ep437 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Real-world effectiveness analysis of oral versus subcutaneous semaglutide in patients with type 2 diabetes mellitus

Ferrer Garcia Juan Carlos , Albalat-Galera Raquel , Moya Victor Atienza , Hernandez Jessica Sanchez , Palomar Luis Arribas , Casamayor Ignacio Ramos , Fullana Ana Artero , Blanco Cintia Gonzalez , Portilla Ana Jimenez , Juan Carlos Sanchez

Background and Objective: Semaglutide, a glucagon-like peptide 1 (GLP1a) receptor agonist, reduces the risk of major adverse cardiovascular events in patients with type 2 diabetes mellitus (DM2). An oral version of semaglutide is now available, and patients may prefer it to the subcutaneous form. Our objective was to compare the effectiveness and safety of both formulations in real life.Methods: Retrospective real-world efficacy analysis including aGLP1-...

ea0063oc10.3 | Adrenal 2 | ECE2019

Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (glucocorticoid receptor) and PDE11A4 (phosphodiesterase 11) in 389 patients

Vaczlavik Anna , Vaduva Patricia , Bouys Lucas , Neou Mario , Septier Amandine , Heurtier Victor , Libe Rossella , Kroiss Matthias , Borson-Chazot Francoise , Chanson Philippe , Vanthyghem Marie-Christine , Tabarin Antoine , Assie Guillaume , Stratakis Constantine , Fragoso Maria , Ragazzon Bruno , Bertherat Jerome

Introduction: PBMAH is an heterogeneous disease from the clinical, hormonal, and morphological point of view. ARMC5 inactivating mutations have been reported as a cause of PBMAH. PDE11A4 variants have been associated with PBMAH and NR3C1 variants with bilateral adrenal incidentalomas.Aim: To analyse the frequency of ARMC5 pathogenic mutations and PDE11A4 and NR3C1 variants in PBMAH patients.<p cla...

ea0049ep1030 | Pituitary - Clinical | ECE2017

Hormone and tumor responses to primary or pre-operative therapy with somatostatin analogs in acromegaly and the relation with T2-weighted MRI signal

Picallo Maria , Centeno Rogelio Garcia , Guerra Aurelio Lopez , Olmedilla Yoko Lucia , Arnoriaga Maria , Requena Maria , Agreda Javier , Andia Victor , Sambo Marcel , Monereo Susana , Velez Maria Angeles , Weber Bettina , Atencia Jose

Objective: Study of the efficacy of SSA in the biochemical and tumour control and the relation between the T2-weighted MRI signal intensity and the response to SSA.Material and methods: 16 patients with GH-secreting pituitary adenomas (7♂/9♀) that received primary or pre-operative treatment with SSA. We classified them according to baseline T2-weighted MRI sequences as Hypo-intense (Ha) and No-Hypo-intense adenomas (no-Ha). Results expressed ...

ea0035p237 | Clinical case reports Pituitary/Adrenal | ECE2014

Hyperprolactinemia secondary to primary hypothyroidism with hyperplasia pituitary

Centeno Rogelio Garcia , Melero Victor Andia , Fernandez Elisa Fernandez , Salas Marcel Sambo , Gonzalez-Antiguedad Cynthia , de la Camara Marta Motilla , Solis Diego Lezcano , Gonzalez Javier , Rivadeneira Lenin , Requena Maria , Ramirez Maria Laura , Olmedilla Yoko , Arnoriaga Maria

Introduction: Although the most common causes of hyperprolactinemia are prolactinoma and iatrogenic, another possible cause is severe primary hypothyroidism, in which the increase of prolactin is a cause of pituitary stimulation by TRH, and can be presented with pituitary hyperplasia.Case report: A 31-year-old woman who comes to endocrinology clinic for hyperprolactinemia, which was detected by symptoms of amenorrhea–galactorrhea. After normal pregn...

ea0035p445 | Diabetes complications | ECE2014

Autoimmune pancreatitis after intravenous insulin desensitization in a diabetic patient allergic to insulin without pancreatic reserve

Salas Marcel Sambo , Melero Victor Andia , Ishishi Yoko Olmedilla , Centeno Rogelio Garcia , Ramirez Maria Laura , Motilla Marta , Antiguedad Cynthia Gonzalez , Requena Maria , Lopez Javier Gonzalez , Rivadeneira Lenin , Arnoriaga Maria

Introduction: Allergy is an uncommon side-effect of insulin treatment in which desensitization represents an alternative when initial approaches are not effective. Autoimmune pancreatitis (AIP) is an even more rare disease that generally has a successful response to corticosteroids. The case of a 50-year-old diabetic man who developed both processes sequentially is presented.Case report: The patient was admitted for acute diabetes mellitus (DM) decompens...

ea0070aep6 | Adrenal and Cardiovascular Endocrinology | ECE2020

Integrated genomics reveals different subgroups of primary bilateral macronodular adrenal hyperplasia (PBMAH)

Vaczlavik Anna , Bouys Lucas , Letouze Eric , Perlemoine Karine , Guignat Laurence , Letourneur Franck , Sibony Mathilde , Bonnet Fidéline , Heurtier Victor , Espiard Stéphanie , Assié Guillaume , Ragazzon Bruno , Bertherat Jerome

Introduction: Primary bilateral macronodular adrenal hyperplasia (PBMAH) are benign adrenocortical disease responsible for benign tumors and cortisol autonomous secretion. There is a broad spectrum of clinical, imaging and hormonal presentations. Aberrant membrane receptor expression is frequent, the most characteristic example being the food dependent Cushing syndrome due to ectopic expression of the GIP receptor (GIP-R). In 20 to 25 % of these patients, inactivating heterozy...